CN101883789B - 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 - Google Patents
特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 Download PDFInfo
- Publication number
- CN101883789B CN101883789B CN200880115546.4A CN200880115546A CN101883789B CN 101883789 B CN101883789 B CN 101883789B CN 200880115546 A CN200880115546 A CN 200880115546A CN 101883789 B CN101883789 B CN 101883789B
- Authority
- CN
- China
- Prior art keywords
- mab
- antibody
- monoclonal antibody
- subtype
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C07K16/108—
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97205907P | 2007-09-13 | 2007-09-13 | |
| US60/972,059 | 2007-09-13 | ||
| PCT/SG2008/000347 WO2009035420A1 (en) | 2007-09-13 | 2008-09-12 | Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210506817.7A Division CN103214570B (zh) | 2007-09-13 | 2008-09-12 | 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101883789A CN101883789A (zh) | 2010-11-10 |
| CN101883789B true CN101883789B (zh) | 2014-10-08 |
Family
ID=40452269
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880115546.4A Expired - Fee Related CN101883789B (zh) | 2007-09-13 | 2008-09-12 | 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 |
| CN201210506817.7A Expired - Fee Related CN103214570B (zh) | 2007-09-13 | 2008-09-12 | 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210506817.7A Expired - Fee Related CN103214570B (zh) | 2007-09-13 | 2008-09-12 | 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8383121B2 (enExample) |
| EP (2) | EP2947094B1 (enExample) |
| JP (1) | JP5490696B2 (enExample) |
| CN (2) | CN101883789B (enExample) |
| AU (1) | AU2008297594B2 (enExample) |
| SG (2) | SG183031A1 (enExample) |
| WO (1) | WO2009035420A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2155787A4 (en) * | 2007-05-11 | 2010-06-16 | Temasek Life Sciences Lab Ltd | SPECIFIC TO THE H5-SUBTYPE BINDING PROTEINS SUITED TO THE DIAGNOSIS AND MONITORING OF THE H5 BIRGRAP |
| EP2265947A4 (en) * | 2008-03-20 | 2011-03-30 | Abay Sa | MULTI-LENGTH WAVE LENGTH ANALYSIS OF SOL-PARTICULATE SPECIFIC BINDING TESTS |
| AU2010247530B2 (en) * | 2009-05-11 | 2016-10-13 | Janssen Vaccines & Prevention B.V. | Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof |
| CN102869379B (zh) * | 2010-04-30 | 2015-04-15 | 淡马锡生命科学研究院有限公司 | H5n1谱系的通用疫苗 |
| WO2012054745A1 (en) * | 2010-10-20 | 2012-04-26 | New York Blood Center, Inc. | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
| JP2013087069A (ja) * | 2011-10-17 | 2013-05-13 | Toyobo Co Ltd | H5亜型インフルエンザウイルスを特異的に認識するモノクローナル抗体 |
| WO2013105896A1 (en) * | 2012-01-12 | 2013-07-18 | Temasek Life Sciences Laboratory Limited | Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3 |
| TW201346040A (zh) * | 2012-03-30 | 2013-11-16 | 田中貴金屬工業股份有限公司 | 流行性感冒a型病毒檢驗用套組 |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| SG11201503878XA (en) * | 2012-11-19 | 2015-06-29 | Temasek Life Sciences Lab Ltd | Monoclonal antibodies targeting neutralizing epitopes on h7 influenza viruses |
| CN104407133A (zh) * | 2014-11-03 | 2015-03-11 | 清华大学深圳研究生院 | A型流感病毒检测方法及其试剂盒 |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| US20170240617A1 (en) | 2016-02-24 | 2017-08-24 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| PL238020B1 (pl) | 2016-09-12 | 2021-06-28 | Inst Biotechnologii I Antybiotykow | Kompozycja przeciwciał monoklonalnych przeciwko hemaglutyninie wirusów grypy serotypu H5 i jej zastosowanie, hybrydomy produkujące rzeczone przeciwciała, sposób diagnozowania infekcji wirusami grypy serotypu H5 oraz zestawy diagnostyczne |
| CN106399265B (zh) * | 2016-09-19 | 2018-03-02 | 中国动物卫生与流行病学中心 | 一种提高禽流感疫苗毒株增殖滴度的方法 |
| CA3088194A1 (en) | 2018-01-26 | 2019-08-01 | Regeneron Pharmaceuticals, Inc. | Human antibodies to influenza hemagglutinin |
| US11230593B2 (en) | 2019-03-25 | 2022-01-25 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| CN110483637B (zh) * | 2019-07-22 | 2022-06-10 | 扬州大学 | 一种抗禽流感病毒神经氨酸酶n2单克隆抗体、编码基因及其应用 |
| CN112574297B (zh) * | 2019-09-27 | 2022-06-24 | 上海生物制品研究所有限责任公司 | 抗神经氨酸酶的单克隆抗体及其应用 |
| WO2021201677A1 (en) | 2020-04-01 | 2021-10-07 | Kiadis Pharma Intellectual Property B.V. | Compositions and methods targeting influenza |
| JP2023551667A (ja) * | 2020-11-23 | 2023-12-12 | ヴィア・バイオテクノロジー・インコーポレイテッド | 抗-インフルエンザ抗体及びその組合せ |
| KR102605065B1 (ko) * | 2021-10-14 | 2023-11-22 | 원광대학교산학협력단 | 고병원성 조류 인플루엔자 바이러스 h5n1에 특이적인 단클론항체 및 이를 이용한 신속 진단 키트 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007089753A2 (en) * | 2006-01-26 | 2007-08-09 | Hx Diagnostics, Inc. | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JP5525688B2 (ja) | 2005-08-19 | 2014-06-18 | 株式会社ビーエル | インフルエンザウイルスh5亜型の免疫検出法 |
| EP1928914A2 (en) | 2005-09-15 | 2008-06-11 | Crucell Holland B.V. | Method for preparing immunoglobulin libraries |
| US8192927B2 (en) | 2006-09-07 | 2012-06-05 | Crucell Holland B.V. | Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| EP2155787A4 (en) * | 2007-05-11 | 2010-06-16 | Temasek Life Sciences Lab Ltd | SPECIFIC TO THE H5-SUBTYPE BINDING PROTEINS SUITED TO THE DIAGNOSIS AND MONITORING OF THE H5 BIRGRAP |
| US7879326B2 (en) * | 2007-06-15 | 2011-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Human neutralizing monoclonal antibodies to H5N1 influenza A virus |
| WO2009035412A1 (en) * | 2007-09-13 | 2009-03-19 | Temasek Life Sciences Laboratory Limited | Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
-
2008
- 2008-09-12 JP JP2010524824A patent/JP5490696B2/ja not_active Expired - Fee Related
- 2008-09-12 WO PCT/SG2008/000347 patent/WO2009035420A1/en not_active Ceased
- 2008-09-12 EP EP15176239.0A patent/EP2947094B1/en not_active Not-in-force
- 2008-09-12 CN CN200880115546.4A patent/CN101883789B/zh not_active Expired - Fee Related
- 2008-09-12 EP EP08830693.1A patent/EP2201039B1/en not_active Not-in-force
- 2008-09-12 US US12/677,971 patent/US8383121B2/en not_active Expired - Fee Related
- 2008-09-12 CN CN201210506817.7A patent/CN103214570B/zh not_active Expired - Fee Related
- 2008-09-12 SG SG2012052098A patent/SG183031A1/en unknown
- 2008-09-12 SG SG2012052106A patent/SG183032A1/en unknown
- 2008-09-12 AU AU2008297594A patent/AU2008297594B2/en not_active Ceased
-
2012
- 2012-09-11 US US13/610,021 patent/US8574581B2/en not_active Expired - Fee Related
- 2012-09-11 US US13/610,054 patent/US8540996B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007089753A2 (en) * | 2006-01-26 | 2007-08-09 | Hx Diagnostics, Inc. | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
Non-Patent Citations (2)
| Title |
|---|
| A latex agglutination test for the rapid detection of avian influenza;CHEN JIANFENG等;《JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION》;20070301;第19卷(第2期);第155-160页 * |
| Pathogenic and molecular characterization of the H5N1 avian influenza virus isolated from the first human case in Zhejiang province, China;Juying Yan等;《Diagnostic Microbiology and Infectious Disease》;20070831;第58卷(第4期);第399-405页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008297594A1 (en) | 2009-03-19 |
| AU2008297594B2 (en) | 2013-06-20 |
| EP2201039A1 (en) | 2010-06-30 |
| US20130004496A1 (en) | 2013-01-03 |
| CN103214570B (zh) | 2014-12-10 |
| SG183032A1 (en) | 2012-08-30 |
| US8540996B2 (en) | 2013-09-24 |
| WO2009035420A1 (en) | 2009-03-19 |
| EP2947094A1 (en) | 2015-11-25 |
| EP2201039A4 (en) | 2012-04-11 |
| US8574581B2 (en) | 2013-11-05 |
| US20100266585A1 (en) | 2010-10-21 |
| JP2010539162A (ja) | 2010-12-16 |
| EP2947094B1 (en) | 2018-11-14 |
| JP5490696B2 (ja) | 2014-05-14 |
| WO2009035420A8 (en) | 2009-05-07 |
| EP2201039B1 (en) | 2015-07-15 |
| SG183031A1 (en) | 2012-08-30 |
| CN101883789A (zh) | 2010-11-10 |
| CN103214570A (zh) | 2013-07-24 |
| US8383121B2 (en) | 2013-02-26 |
| US20130004497A1 (en) | 2013-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101883789B (zh) | 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 | |
| EP2207804B1 (en) | Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof | |
| AU2007353481B2 (en) | H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance | |
| AU2013224734A1 (en) | Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof | |
| CN102718863A (zh) | 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白 | |
| HK1161725B (en) | H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141008 |